Clinical characteristics and outcomes of immunosuppressed patients hospitalized with COVID‐19: Experience from London

By Vaid N, Ardissino M, Reed TAN, et al
Published September 23, 2020

Key Takeaways

Researchers investigated if and how the use of immunosuppressant medication is associated with outcomes of patients hospitalized with COVID‐19. Among 981 assessed patients who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), 354 (36.1%) patients died during the follow‐up period. Observations revealed significantly higher mortality rates in the immunosuppressed cohort (= 31). The current UK government’s early isolation ('shielding') policy for these individuals was thus further supported by the results.

Read the full article on Journal of Internal Medicine.

Share with emailShare to FacebookShare to LinkedInShare to Twitter